Met kinase inhibitors
US7547782B2 · kind B2 · utility
5Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2006 |
| Grant date | Jun 16, 2009 |
| Priority date | — |
| Expiry date | Jan 18, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds having the formula I or II:including salts thereof, and methods for using them for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.